Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBlackrock I&g Regulatory News (BRIG)

Share Price Information for Blackrock I&g (BRIG)

Share Price is delayed by 15 minutes
Get Live Data
229.00    0.00 (0.00%)
Bid:
224.00
Ask:
234.00
Spread: 10.00 (4.464%)
Market Cap: £42.65m
BRIG Live PriceLast checked at - London Stock Exchange

Intraday Blackrock I&g Share Chart

Portfolio Update

23 Jan 2026 15:29

BlackRock Income and Growth Investment Trust Plc - Portfolio Update

BlackRock Income and Growth Investment Trust Plc - Portfolio Update

PR Newswire

LONDON, United Kingdom, January 23

BLACKROCK INCOME & GROWTH INVESTMENT TRUST PLC (LEI:5493003YBY59H9EJLJ16 )

All information is at 31 December 2025 and unaudited.

 

Performance at month end with net income reinvested

One

Month

Three

Months

One

Year

Three

Years

Five

Years

Since

1 April

2012

Sterling

Share price

2.3%

7.8%

15.8%

29.2%

55.4%

171.5%

Net asset value

2.5%

6.0%

16.2%

36.7%

56.7%

176.8%

FTSE All-Share Total Return

2.2%

6.4%

24.0%

46.5%

73.9%

191.9%

 

Source: BlackRock

 

BlackRock took over the investment management of the Company with effect from 1 April 2012.

At month end

Sterling:

Net asset value - capital only:

244.90p

Net asset value - cum income*:

250.73p

Share price:

220.00p

Total assets (including income):

£53.4m

Discount to cum-income NAV:

12.3%

Gearing:

4.6%

Net yield**:

3.5%

Ordinary shares in issue***:

18,918,794

Gearing range (as a % of net assets):

0-20%

Ongoing charges****:

1.15%

 

* Includes net revenue of 5.83 pence per share

** The Company's yield based on dividends announced in the last 12 months as at the date of the release of this announcement is 3.5% and includes the 2024 final dividend of 4.90p per share declared on 07 January 2025 with pay date 14 March 2025 and the Interim Dividend of 2.70p per share declared on 19 June 2025 with pay date 02 September 2025.

*** excludes 10,081,532 shares held in treasury.

**** The Company's ongoing charges are calculated as a percentage of average daily net assets and using management fee and all other operating expenses excluding finance costs, direct transaction costs, custody transaction charges, VAT recovered, taxation and certain non-recurring items for the year ended 31 October 2024. In addition, the Company's Manager has also agreed to cap ongoing charges by rebating a portion of the management fee to the extent that the Company's ongoing charges exceed 1.15% of average net assets.

 

 

Sector Analysis

Total assets (%)

Banks

13.0

Pharmaceuticals & Biotechnology

7.7

Nonequity Investment Instruments

6.9

Aerospace & Defense

5.6

Oil & Gas Producers

4.9

Mining

4.9

Financial Services

4.6

General Retailers

4.5

Nonlife Insurance

4.4

Software & Computer Services

4.3

Household Goods & Home Construction

4.1

Real Estate Investment Trusts

3.6

Personal Goods

3.4

Support Services

3.3

Electronic & Electrical Equipment

3.0

Life Insurance

2.8

Travel & Leisure

2.6

Tobacco

2.5

Industrial Engineering

2.4

Electricity

2.1

General Industrials

1.0

Food Producers

0.7

Beverages

0.5

Net Current Assets

7.2

 

-----

Total

100.0

 

=====

Country Analysis

Percentage

 

United Kingdom

90.7

United States

2.1

Net Current Assets

7.2

 

-----

 

100.0

 

 

Top 10 Holdings

Fund %

 

AstraZeneca

7.2

Standard Chartered

4.6

RELX

4.6

Lloyds Banking Group

4.2

HSBC

4.0

Shell

3.9

Reckitt

3.7

Unilever

3.7

Rio Tinto

3.5

Phoenix Group

2.9

 

 

Commenting on the markets, representing the Investment Manager noted:

 

Market Summary:

December wrapped up a strong albeit volatile year for global equities, with many indexes finishing at or near record highs - a sharp contrast to the sluggish close of December 2024. The MSCI All Countries World Index advanced +1.1% in the month, marking its third straight year of double-digit gains despite consistent bouts of volatility.

 

In the UK, the Bank of England delivered a 25bps rate cut mid-month to the lowest level in 3 years, supporting equity markets. Inflation cooled more than expected, though wage growth and sticky food prices kept policymakers cautious about further easing. The FTSE All-Share gained +2.2%, driven by financials and materials. Across Europe, the STOXX 600 surged to all-time highs, up +3.1% in USD terms for December and an eye-catching +37% for the year - powered by dollar weakness, falling interest rates, Germany's fiscal boost, and rotations out of US tech names at the start of the year.

 

In the US, things were choppier. Despite an optimistic start, AI funding jitters sparked a tech wobble mid-month (NDX - 1.8% on December 17). Still, sentiment improved after the Fed's rate cut and a softer CPI print. The Nasdaq ended December down -0.67%, and the S&P 500 eked out +0.1% for the month.

 

Looking at 2025, global equities have had another stellar run. Europe stole the spotlight (in USD terms) with +37% for the year with the total return for UK All Share also up strongly, +24% in GBP or +33% in USD. US stocks lagged the MSCI ACWI ex-US index by the widest margin since 2009*, despite continued tech dominance. AI was the megatrend of the year, driving hyperscaler capex, despite bouts of tech jitters. Elsewhere, commodities were equally dramatic as gold surged ~65% through the year, and silver was up ~140%*.

 

Stock comments

 

The biggest contributor to performance for the month was Standard Chartered, which rallied in step with the broader financials sector as investors rotated into cyclicals given policy easing and softening inflation signals. Phoenix Group also contributed as the shares did well following relief from the Autumn Budget when the bond market remained stable, and also given rotation into UK financials through the month. The underweight in Diageo contributed as the shares fell due to ongoing concerns over weak volume growth. Sentiment was further pressured by UBS's early-December downgrade, citing persistent softness in the US spirits market. Rio Tinto, contributed in December, benefitting from strong trends in commodity prices.

 

Detractors this month were a function of underweight positions. HSBC (underweight) and Barclays (not owned) both rallied sharply as investors rotated into cyclicals with financials in particular performing well following the November Budget and associated bond market stability, as well as a broader shift toward value stocks in Europe. UK banks building on their strong year-to-date gains (+68%). Glencore (not owned) also detracted after copper prices reached new all-time highs early in the month, driven by structural supply deficits. The company also performed well on raised copper production numbers ahead of their capital markets day at the start of the month. Next detracted during the month on limited stock specific news.

 

Changes

 

We were focused mainly on ensuring the fund was in a good place for the start of 2026, re-underwriting investment cases and pruning areas where conviction was lower and allocating to those names where we see most opportunity. There were no major purchases or disposals in the month.

During the period, we reduced BP and Shell following strong runs despite weak energy prices and weak earnings. We also added to Rolls-Royce given the strong outlook for civil aerospace, defence and data centre expenditure.

 

Outlook

 

The outlook for investment markets continues to be driven by a complex interplay of elevated geopolitical uncertainty, easing monetary policy and strong thematic winds in AI, Defence and Financials sectors. The first half of 2025 saw global markets fall sharply as tariffs were threatened only to be followed by an impressive recovery as proposed tariff levels were lowered and their implementation delayed. However, tariffs remain a key source of market volatility with the potential for outsized impacts on specific industries and companies. Expectations of Fed rate cuts have consistently been pushed out this year. US President Trump's unpredictability, whether tariff related or more generally, suggests volatility in both equity and bond markets is likely to remain elevated. These factors have also driven weakness in the US Dollar impacting companies with USD earnings. Our response is to focus on those companies that have strong and sustainable competitive advantages alongside sufficient pricing power to navigate these uncertain times while seeking opportunities that may result from elevated volatility in markets.

 

The outlook for Europe is buoyed by a combination of rate cuts by the ECB (from 3.0% to 2.0%) and significant fiscal expansion from Germany with an emphasis on defence and infrastructure spending. This has already led to the significant outperformance of European defence exposed companies though the question is whether this spend stimulates economic activity more broadly in Germany and then Europe as a whole. In our conversations with corporates, those exposed to highlighted industries, such as defence, are very optimistic, yet the outlook more generally suggests stabilisation rather than anything more for now. Meanwhile, China continues to fight weak domestic demand and deflationary pressures with a broad range of fiscal and monetary tools with limited success to date; the uncertainty created by US tariff announcements clearly hampering their efforts.

 

The UK index continues to be relatively immune to the political challenges of the UK government and economy, as the strong performance during 2025. However, for the domestic exposed companies which represent c.20% of the index, the challenges of politics have been notable for investor confidence. The hope of `certainty' delivered by a large majority in 2024, has given way to an elevated equity risk premium as both equity, and indeed gilt markets, continue to suffer from the fractures within this majority. Whilst fiscal consolidation is welcomed as the sensible path for a highly indebted nation, there remains little confidence in either its delivery or its architects surviving a potential leadership challenge. The UK saver remains robust, with high savings rates and real wages continue to grow highlighting the potential for UK economic recovery when consumer and business confidence improves. While economic data has shown signs of stability, uncertainty around the growth outlook and future policy direction has constrained investor confidence.

 

The UK stock market remains very depressed in valuation terms relative to other developed markets offering double-digit discounts across a range of valuation metrics. This valuation anomaly saw further reactions from UK corporates who continue to use excess cashflows to fund buybacks. Combining this with a dividend yield of 3.2% (FTSE All Share Index yield as at end of October 2025; source: FT), the cash return of the UK market is attractive in absolute terms and higher than other developed markets. This valuation anomaly has also been evidenced by the continuation of inbound M&A for UK listed companies. Although we anticipate further volatility ahead, we believe that risk appetite will return and opportunities are emerging.

 

We continue to focus the portfolio on cash generative businesses that we believe offer durable, competitive advantages as we believe these companies are best placed to drive superior returns over the long term. Whilst we anticipate economic and market volatility will persist throughout the year ahead, we expect that this will create opportunities; by seeking to identify the companies that strengthen their long-term prospects as well as attractive turnaround situations.

 

*Source: The Financial Times as at 29th December 2025 https://www.ft.com/content/10a8a099-5719-42ce-a2eb-edc3045a632f

*Source: As at 31st December 2025 Record Gold Price Ends 2025 Up 65%, Silver Jumps 144% | Gold News

 

23 January 2026

 

 


Release

Date   Source Headline
5th Jun 202612:08 pmPRNNet Asset Value(s)
4th Jun 20261:15 pmPRNNet Asset Value(s)
3rd Jun 202612:41 pmPRNNet Asset Value(s)
2nd Jun 202612:54 pmPRNNet Asset Value(s)
1st Jun 202612:03 pmPRNNet Asset Value(s)
1st Jun 202611:25 amPRNTotal Voting Rights
29th May 202612:09 pmPRNNet Asset Value(s)
28th May 202612:19 pmPRNNet Asset Value(s)
27th May 202611:50 amPRNNet Asset Value(s)
26th May 202611:43 amPRNNet Asset Value(s)
22nd May 202612:33 pmPRNNet Asset Value(s)
21st May 202611:59 amPRNNet Asset Value(s)
20th May 202612:17 pmPRNNet Asset Value(s)
20th May 202611:02 amPRNPortfolio Update
19th May 202611:57 amPRNNet Asset Value(s)
18th May 202612:57 pmPRNNet Asset Value(s)
15th May 202612:16 pmPRNNet Asset Value(s)
14th May 202611:41 amPRNNet Asset Value(s)
13th May 202612:14 pmPRNNet Asset Value(s)
12th May 202612:44 pmPRNMandatory Closed Period Compliance with MAR
12th May 202612:16 pmPRNNet Asset Value(s)
11th May 202612:00 pmPRNNet Asset Value(s)
8th May 202611:59 amPRNNet Asset Value(s)
7th May 202612:21 pmPRNNet Asset Value(s)
6th May 202612:35 pmPRNNet Asset Value(s)
6th May 20269:09 amPRNCompliance with Listing Rule 15.6.8R
5th May 20261:16 pmPRNDisclosure of Portfolio Holdings
5th May 202611:57 amPRNNet Asset Value(s)
1st May 202612:19 pmPRNNet Asset Value(s)
1st May 20267:00 amPRNTotal Voting Rights
30th Apr 202611:43 amPRNNet Asset Value(s)
29th Apr 202611:38 amPRNNet Asset Value(s)
28th Apr 202611:25 amPRNNet Asset Value(s)
27th Apr 202611:39 amPRNNet Asset Value(s)
24th Apr 202611:22 amPRNNet Asset Value(s)
23rd Apr 202612:02 pmPRNNet Asset Value(s)
23rd Apr 20267:00 amPRNTotal Voting Rights
22nd Apr 202612:22 pmPRNNet Asset Value(s)
21st Apr 20265:18 pmPRNTransaction in Own Shares
21st Apr 20261:55 pmPRNNet Asset Value(s)
20th Apr 202612:16 pmPRNNet Asset Value(s)
20th Apr 202610:32 amPRNPortfolio Update
17th Apr 20261:09 pmPRNNet Asset Value(s)
17th Apr 20267:00 amPRNTotal Voting Rights
16th Apr 202611:52 amPRNNet Asset Value(s)
15th Apr 20265:50 pmPRNTransaction in Own Shares
15th Apr 202611:48 amPRNNet Asset Value(s)
14th Apr 202611:41 amPRNNet Asset Value(s)
13th Apr 202611:58 amPRNNet Asset Value(s)
10th Apr 202612:21 pmPRNNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.